DrugPatentWatch adds Supplementary Protection Certificates

DrugPatentWatchdrugpatentwatch-pin has expanded its global coverage of pharmaceutical patents by adding coverage of Supplementary Protection Certificates.

DrugPatentWatch provides deep knowledge on pharmaceutical drugs and the 90,000 global patents covering them. Uses cases include:

Payers: Formulary and pharmacy & therapeutics (P&T)

Anticipate future budget requirements and proactively identify generic sources

Branded pharmaceutical manufacturers

Assess past successes of patent challengers and elucidate research paths of competitors

Specialty pharmaceuticals and generics

Identify market entry opportunities and inform portfolio management decisions

Buyers, wholesalers, and distributors

Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs

API manufacturers

Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers

The addition of Supplementary Protection Certificates expands coverage of European markets, and helps identify drugs which have these patent extensions.

For more information see www.DrugPatentWatch.com or sign up for a free trial at www.DrugPatentWatch.com/trial.php

Comments are closed.